Cite
Rumi E, Boveri E, Bellini M, et al. Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria. Oncotarget. 2017;8(60):101735-101744doi: 10.18632/oncotarget.21594.
Rumi, E., Boveri, E., Bellini, M., Pietra, D., Ferretti, V. V., Sant'Antonio, E., Cavalloni, C., Casetti, I. C., Roncoroni, E., Ciboddo, M., Benvenuti, P., Landini, B., Fugazza, E., Troletti, D., Astori, C., Cazzola, M. (2017). Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria. Oncotarget, 8(60), 101735-101744. https://doi.org/10.18632/oncotarget.21594
Rumi, Elisa, et al. "Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria." Oncotarget vol. 8,60 (2017): 101735-101744. doi: https://doi.org/10.18632/oncotarget.21594
Rumi E, Boveri E, Bellini M, Pietra D, Ferretti VV, Sant'Antonio E, Cavalloni C, Casetti IC, Roncoroni E, Ciboddo M, Benvenuti P, Landini B, Fugazza E, Troletti D, Astori C, Cazzola M. Clinical course and outcome of essential thrombocythemia and prefibrotic myelofibrosis according to the revised WHO 2016 diagnostic criteria. Oncotarget. 2017 Oct 06;8(60):101735-101744. doi: 10.18632/oncotarget.21594. eCollection 2017 Nov 24. PMID: 29254200; PMCID: PMC5731910.
Copy
Download .nbib